Melinda Van Roey

690 total citations
9 papers, 566 citations indexed

About

Melinda Van Roey is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Melinda Van Roey has authored 9 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Melinda Van Roey's work include Virus-based gene therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and RNA Interference and Gene Delivery (2 papers). Melinda Van Roey is often cited by papers focused on Virus-based gene therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and RNA Interference and Gene Delivery (2 papers). Melinda Van Roey collaborates with scholars based in United States and France. Melinda Van Roey's co-authors include James G. McArthur, Марина Москаленко, Brian A. Donahue, Richard O. Snyder, Salil D. Patel, Lili Chen, Ying Ge, Karin Jooss, Sandra Powell and Shanthi Ganesh and has published in prestigious journals such as Blood, Nature Biotechnology and Journal of Virology.

In The Last Decade

Melinda Van Roey

9 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melinda Van Roey United States 8 450 385 180 74 65 9 566
Hengjun Chao United States 11 737 1.6× 706 1.8× 318 1.8× 59 0.8× 128 2.0× 17 994
Kerstin Sollerbrant Sweden 15 330 0.7× 465 1.2× 118 0.7× 31 0.4× 161 2.5× 19 704
Nicole C. Hasbrouck United States 5 550 1.2× 470 1.2× 228 1.3× 72 1.0× 87 1.3× 8 677
Fabienne Stoeckel France 7 374 0.8× 324 0.8× 157 0.9× 40 0.5× 23 0.4× 8 505
Show-Li Chen Taiwan 13 238 0.5× 299 0.8× 169 0.9× 140 1.9× 82 1.3× 16 582
Scott S. Case United States 9 543 1.2× 532 1.4× 165 0.9× 59 0.8× 17 0.3× 11 726
Irene Gil-Fariña Germany 10 368 0.8× 420 1.1× 131 0.7× 54 0.7× 37 0.6× 24 617
Pierre Chenuaud France 5 434 1.0× 472 1.2× 63 0.3× 60 0.8× 59 0.9× 5 573
Irene C. Schneider Germany 13 361 0.8× 334 0.9× 202 1.1× 104 1.4× 27 0.4× 21 554
Frederik H.E. Schagen Netherlands 13 353 0.8× 331 0.9× 198 1.1× 42 0.6× 16 0.2× 18 572

Countries citing papers authored by Melinda Van Roey

Since Specialization
Citations

This map shows the geographic impact of Melinda Van Roey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda Van Roey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda Van Roey more than expected).

Fields of papers citing papers by Melinda Van Roey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda Van Roey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda Van Roey. The network helps show where Melinda Van Roey may publish in the future.

Co-authorship network of co-authors of Melinda Van Roey

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda Van Roey. A scholar is included among the top collaborators of Melinda Van Roey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda Van Roey. Melinda Van Roey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Liang, Spencer C., Марина Москаленко, Melinda Van Roey, & Karin Jooss. (2013). Depletion of regulatory T cells by targeting folate receptor 4 enhances the potency of a GM-CSF-secreting tumor cell immunotherapy. Clinical Immunology. 148(2). 287–298. 21 indexed citations
2.
Ganesh, Shanthi, et al.. (2009). Evaluation of Biodistribution of a Fiber-Chimeric, Conditionally Replication-Competent (Oncolytic) Adenovirus in CD46 Receptor Transgenic Mice. Human Gene Therapy. 20(10). 1201–1213. 7 indexed citations
3.
Ganesh, Shanthi, et al.. (2008). Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models. Clinical Cancer Research. 14(12). 3933–3941. 75 indexed citations
4.
Tsui, Lisa, Michael T. Kelly, Ying Ge, et al.. (2002). Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nature Biotechnology. 20(1). 53–57. 50 indexed citations
5.
Ge, Ying, Sandra Powell, Melinda Van Roey, & James G. McArthur. (2001). Factors influencing the development of an anti–factor IX (FIX) immune response following administration of adeno-associated virus–FIX. Blood. 97(12). 3733–3737. 77 indexed citations
6.
Москаленко, Марина, Lili Chen, Melinda Van Roey, et al.. (2000). Epitope Mapping of Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy and Virus Structure. Journal of Virology. 74(4). 1761–1766. 201 indexed citations
7.
Patel, Salil D., Ying Ge, Марина Москаленко, et al.. (2000). The p53-Independent Tumoricidal Activity of an Adenoviral Vector Encoding a p27–p16 Fusion Tumor Suppressor Gene. Molecular Therapy. 2(2). 161–169. 16 indexed citations
8.
Rendahl, Katherine G., Stuart E. Leff, Gillis R. Otten, et al.. (1998). Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nature Biotechnology. 16(8). 757–761. 93 indexed citations
9.
Medhkour, Azedine, et al.. (1989). Implantation of human meningiomas into the subrenal capsule of the nude mouse. Journal of neurosurgery. 71(4). 545–550. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hengjun Chao Breakdown of academic impact, for papers by Kerstin Sollerbrant Breakdown of academic impact, for papers by Nicole C. Hasbrouck Breakdown of academic impact, for papers by Fabienne Stoeckel Breakdown of academic impact, for papers by Show-Li Chen Breakdown of academic impact, for papers by Scott S. Case Breakdown of academic impact, for papers by Irene Gil-Fariña Breakdown of academic impact, for papers by Pierre Chenuaud Breakdown of academic impact, for papers by Irene C. Schneider Breakdown of academic impact, for papers by Frederik H.E. Schagen
Rankless by CCL
2026